Physician profile
Eric D Kanter
NPI 1558365411
$725.46
in general payments reported to CMS, 2019-2025
11 companies · $50.64 in 2025
The $50.64 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $26.86 · 2023: $304 · 2024: $160 · 2025: $50.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $515.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $514.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $134.55 | 2023 | Ngenuity |
| Genentech USA, INC. | $101.30 | 2019-2023 | Vabysmo, Lucentis |
| Abbvie INC. | $86.16 | 2023-2024 | |
| Regeneron Healthcare Solutions, INC. | $83.61 | 2019-2024 | Eylea |
| Astellas Pharma US INC | $76.97 | 2023-2024 | Izervay |
| Novartis Pharmaceuticals Corporation | $58.82 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $45.88 | 2023-2025 | Syfovre |
| Biogen, INC. | $45.24 | 2023-2024 | Byooviz |
| Alimera Sciences, INC. | $40.25 | 2019 | |
| US Oncology Corporate, INC. | $29.10 | 2025 | |
| Allergan, INC. | $23.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Kanter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.